SCHEMBL14632152

SCHEMBL14632152

Cc1ccc(-c2nc3ccccn3c2C(O)Nc2ccccn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
ADORA1 P30542 1/20 0.43
MAPT P10636 8/20 0.43
TP53 P04637 5/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 5/20 0.42
KDM4E B2RXH2 4/20 0.41
GAA P10253 6/20 0.39
TDP1 Q9NUW8 4/20 0.39
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
KMT2A Q03164 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 1/20 0.39
GFER P55789 1/20 0.39
NTRK1 P04629 2/20 0.38
HPGD P15428 2/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396205 0.78 ALOX5 (0.44) ALDH1A1NPC1RAB9AMAPTTP53
SCHEMBL3391489 0.77 DPP4 (0.50) ALDH1A1NPC1RAB9AMAPTTP53
SCHEMBL3393907 0.70 TP53 (0.45) ALDH1A1NPC1RAB9AMAPTTP53
SCHEMBL3360536 0.70 TP53 (0.40) ALDH1A1MAPTTP53SMN1; SMN2KDM4E
SCHEMBL3363076 0.70 MAPT (0.48) ALDH1A1MAPTTP53KDM4EGAA
SCHEMBL3434736 0.70 NR1H4 (0.49) ALDH1A1NPC1RAB9ATP53SMN1; SMN2
SCHEMBL14646318 0.69 NPC1 (0.77) ALDH1A1NPC1RAB9AADORA1MAPT
SCHEMBL3433131 0.68 MDM2 (0.41) ALDH1A1MAPTTP53SMN1; SMN2KDM4E
SCHEMBL22615082 0.67 NPC1 (0.62) ALDH1A1NPC1RAB9AADORA1MAPT
SCHEMBL18221717 0.67 NPC1 (0.63) ALDH1A1NPC1RAB9AADORA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 ALDH1A1 65/4885NPC1 1153/4885RAB9A 3798/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT ALDH1A1 192/4885NPC1 2286/4885RAB9A 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.